Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1051 of 6351
-
New transplant approach offers hope for sickle cell patients without a perfect donor match
Disease control OngoingBlood stem cells can produce red blood cells (which carry oxygen), white blood cells of the immune system (which fight infections) and platelets (which help the blood clot). Patients with sickle cell disease produce abnormal red blood cells. A blood stem cell transplant from a d…
Phase 1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Syringe exchange clinics offer new hope for opioid addiction treatment
Disease control CompletedThis trial will recruit syringe exchange participants with opioid use disorder in New York City and test whether starting buprenorphine treatment at the syringe exchange program is more effective than referral to a community health center for buprenorphine treatment.
Phase 2 • Sponsor: Montefiore Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Cord blood stem cells boost recovery in High-Risk cancer patients
Disease control OngoingThis is an single arm, open label, interventional phase II trial evaluating the efficacy of umbilical cord blood (UCB) hematopoietic stem and progenitor cells (HSPC) expanded in culture with stimulatory cytokines (SCF, Flt-3L, IL-6 and thromopoietin) on lympho-hematopoietic recov…
Phase 2 • Sponsor: Masonic Cancer Center, University of Minnesota • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Immunotherapy-Chemo combo shows promise in aggressive lymphoma trial
Disease control OngoingThis phase II trial studies how well nivolumab works with the DA-REPOCH chemotherapy regimen in treating patients with aggressive B-cell non-Hodgkin lymphoma. Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body?s immune system attack the cancer, and may…
Phase 2 • Sponsor: David Bond, MD • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Could a simple exercise breathing test replace invasive heart probes?
Diagnosis CompletedIn Patients with stable Angina pectoris CCS 1-3 exercise testing for ischemia detection is widely used despite the known limitations. Measurement of the FFR is invasive but gold standard for Ischemia detection. Adding of parameters of spiroergometer might help to improve diagnos…
Sponsor: Jena University Hospital • Aim: Diagnosis
Last updated Aug 08, 2026 00:03 UTC
-
Immunotherapy drug nivolumab takes on rare blood cancer in kids and adults
Disease control OngoingProspective, non-randomized, single arm phase II trial with 2 cohorts of ALK+ ALCL treated with nivolumab
Phase 2 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
Can a Drug-Coated balloon beat a stent for tough heart attacks?
Disease control Recruiting nowThis is a single-center, retrospective, propensity-score-matched observational study. It aims to compare the rate of immediate slow-flow or no-reflow after percutaneous coronary intervention (PCI) between drug-coated balloon (DCB) and drug-eluting stent (DES) in STEMI patients wi…
Sponsor: Xijing Hospital • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
New AI reads CT scans to predict which esophageal cancers vanish after treatment
Diagnosis CompletedThis multicenter, retrospective cohort study reviews the medical records and CT scans of adults with esophageal squamous cell carcinoma (ESCC) who received neoadjuvant immunotherapy plus chemotherapy before surgery at three hospitals in China. The goal is to develop and validate …
Sponsor: Nanjing Medical University • Aim: Diagnosis
Last updated Jun 26, 2026 18:28 UTC
-
Common painkiller may boost lung cancer Drug's power
Disease control CompletedThe third generation epidermal growth factor receptor-tyrosine Kinase Inhibitor(EGFR-TKI) osimertinib has obvious curative effect for EGFR sensitive mutation and T790M mutation(PMID 27959700), but acquired drug resistance will occur. Previous studies show that apoptosis escape ca…
Phase 2 • Sponsor: Daping Hospital and the Research Institute of Surgery of the Third Military Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Can a scan replace the needle? ultrasound and MRI put to the test against liver biopsy for fatty liver disease
Diagnosis CompletedNon-alcoholic fatty liver disease (NAFLD) is a highly prevalent condition, and when fatty liver is associated with inflammation and hepatocellular injury (steatohepatitis), it can lead to fibrosis, cirrhosis, liver failure and hepatocellular carcinoma. Liver biopsy is the gold st…
Sponsor: Azienda USL Reggio Emilia - IRCCS • Aim: Diagnosis
Last updated Jul 26, 2026 00:00 UTC
-
AI takes on hip pain: could a computer spot impingement before it worsens?
Diagnosis CompletedFemoroacetabular impingement syndrome (FAIS) is the leading cause of hip pain in young adults and frequently progresses to osteoarthritis, often exacerbated by delayed diagnosis in primary care. Current AI models for FAIS diagnosis primarily rely on single imaging modalities, lim…
Sponsor: ChunBao Li • Aim: Diagnosis
Last updated Aug 01, 2026 00:00 UTC
-
The quest to decode the genetic blueprint of developmental disorders
Knowledge-focused CompletedThe DEVO-DECODE project aims to align our currently limited knowledge currently limited knowledge of the genetic architecture of developmental with our more advanced knowledge of their "phenome". To this end, we aim to establish a homogeneous cohort of patients with with develop…
Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Aug 22, 2026 00:00 UTC
-
Can a new enzyme therapy tame MPS II over time?
Disease control OngoingA Phase II open-label, parallel group, 2 sites (Brazil), designed to evaluate the long term safety and efficacy of study drug for the treatment of the MPS II.
Phase 2 • Sponsor: JCR Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Robot-Guided surgery plus Clot-Busting drug aims to improve brain bleed recovery
Disease control OngoingSpontaneous cerebral hemorrhage is one of the main causes of death and disability all over the world, accounting for 20%-30% of all cerebrovascular diseases. Minimally invasive surgery of cerebral hemorrhage, especially puncture aspiration, can improve early and long-term neurolo…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
AI model could spare diabetes patients from invasive kidney biopsies
Diagnosis CompletedThis multicenter retrospective observational study aims to develop and validate an interpretable machine learning model for differentiating diabetic kidney disease (DKD) from non-diabetic kidney disease (NDKD) in patients with type 2 diabetes mellitus. Clinical, laboratory, and p…
Sponsor: Beijing Tongren Hospital • Aim: Diagnosis
Last updated Jul 01, 2026 00:00 UTC
-
Radioactive seeds zapped tumors from inside – early trial shows promise
Disease control OngoingA unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for superficial cutaneous, mucosal or soft tissue neoplasia
Sponsor: Alpha Tau Medical LTD. • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New combo attack on stubborn cancers shows promise in early trial
Disease control CompletedThis phase II trial studies how well nivolumab and temozolomide work in treating patients with small-cell lung cancer that has come back or does not respond to treatment, or neuroendocrine cancer that has spread to other places in the body. Immunotherapy with monoclonal antibodie…
Phase 2 • Sponsor: Dwight Owen • Aim: Disease control
Last updated Aug 20, 2026 00:00 UTC
-
New hope for tough leukemia cases: drug combo trial opens for kids and young adults
Disease control Recruiting nowThis study evaluates the safety and tolerability of combining venetoclax with Vyxeos (CPX-351) in pediatric and young adult patients with acute leukemia that has come back or not responded to treatment.
Phase 1 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Lung cancer patients may soon get immunotherapy as a quick shot instead of a long IV drip
Disease control CompletedThis study will evaluate the pharmacokinetics, safety, and efficacy of atezolizumab subcutaneous (SC) compared with atezolizumab intravenous (IV) in participants with locally advanced or metastatic Non-Small Cell Lung Cancer (NSCLC) who have not been exposed to cancer immunothera…
Phase 3 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Ultrasound-Guided stenting may cut heart risks in complex cases
Disease control OngoingThis study is designed to investigate whether IVUS-guided DK crush stenting technique compared to angiography-guided DK crush after the indexed procedure will lead to lower rates of the composite endpoint of target vessel failure (TVF) at 12 months. The individual components of T…
Sponsor: Nanjing First Hospital, Nanjing Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC